References
Key articles
European Society of Human Reproduction and Embryology (ESHRE). Guideline on the management of recurrent pregnancy loss. Feb 2023 [internet publication].Full text
Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012 Nov;98(5):1103-11. Abstract
Royal College of Obstetricians and Gynaecologists. Recurrent miscarriage: green-top guideline no. 17. Jun 2023 [internet publication].Full text Abstract
Jauniaux E, Farquharson RG, Christiansen OB, et al. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2006 Sep;21(9):2216-22.Full text Abstract
Reference articles
1. European Society of Human Reproduction and Embryology (ESHRE). Guideline on the management of recurrent pregnancy loss. Feb 2023 [internet publication].Full text
2. Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012 Nov;98(5):1103-11. Abstract
3. Stirrat GM. Recurrent miscarriage. Lancet. 1990 Sep 15;336(8716):673-5. Abstract
4. Ng KYB, Cherian G, Kermack AJ, et al. Systematic review and meta-analysis of female lifestyle factors and risk of recurrent pregnancy loss. Sci Rep. 2021 Mar 29;11(1):7081.Full text Abstract
5. Habayeb OM, Konje JC. The one-stop recurrent miscarriage clinic: an evaluation of its effectiveness and outcome. Hum Reprod. 2004 Dec;19(12):2952-8.Full text Abstract
6. Toth B, Bohlmann M, Hancke K, et al. Recurrent miscarriage: diagnostic and therapeutic procedures. Guideline of the DGGG, OEGGG and SGGG (S2k-Level, AWMF Registry No. 015/050, May 2022). Geburtshilfe Frauenheilkd. 2023 Jan;83(1):49-78.Full text Abstract
7. Quenby SM, Farquharson RG. Predicting recurring miscarriage: what is important? Obstet Gynecol. 1993 Jul;82(1):132-8. Abstract
8. Hennessy M, Dennehy R, Meaney S, et al. Clinical practice guidelines for recurrent miscarriage in high-income countries: a systematic review. Reprod Biomed Online. 2021 Jun;42(6):1146-71.Full text Abstract
9. Brigham SA, Conlon C, Farquharson RG. A longitudinal study of pregnancy outcome following idiopathic recurrent miscarriage. Hum Reprod. 1999 Nov;14(11):2868-71.Full text Abstract
10. Kleinhaus K, Perrin M, Friedlander Y, et al. Paternal age and spontaneous abortion. Obstet Gynecol. 2006 Aug;108(2):369-77. Abstract
11. Nguyen BT, Chang EJ, Bendikson KA. Advanced paternal age and the risk of spontaneous abortion: an analysis of the combined 2011-2013 and 2013-2015 National Survey of Family Growth. Am J Obstet Gynecol. 2019 Nov;221(5):476.e1-7. Abstract
12. du Fossé NA, van der Hoorn MP, van Lith JMM, et al. Advanced paternal age is associated with an increased risk of spontaneous miscarriage: a systematic review and meta-analysis. Hum Reprod Update. 2020 Sep 1;26(5):650-69.Full text Abstract
13. Slama R, Bouyer J, Windham G, et al. Influence of paternal age on the risk of spontaneous abortion. Am J Epidemiol. 2005 May 1;161(9):816-23.Full text Abstract
14. Regan L, Braude PR, Trembath PL. Influence of past reproductive performance on risk of spontaneous abortion. BMJ. 1989 Aug 26;299(6698):541-5.Full text Abstract
15. Ogasawara M, Aoki K, Okada S, et al. Embryonic karyotype of abortuses in relation to the number of previous miscarriages. Fertil Steril. 2000 Feb;73(2):300-4. Abstract
16. Hogge WA, Byrnes AL, Lanasa MC, et al. The clinical use of karyotyping spontaneous abortions. Am J Obstet Gynecol. 2003 Aug;189(2):397-400. Abstract
17. Clifford K, Rai R, Watson H, et al. An informative protocol for the investigation of recurrent miscarriage: preliminary experience of 500 consecutive cases. Hum Reprod. 1994 Jul;9(7):1328-32. Abstract
18. Carp H, Feldman B, Oelsner G, et al. Parental karyotype and subsequent live births in recurrent miscarriage. Fertil Steril. 2004 May;81(5):1296-301. Abstract
19. Stephenson MD, Sierra S. Reproductive outcomes in recurrent pregnancy loss associated with a parental carrier of a structural chromosome rearrangement. Hum Reprod. 2006 Apr;21(4):1076-82.Full text Abstract
20. Pasquier E, Bohec C, De Saint Martin L, et al. Strong evidence that skewed X-chromosome inactivation is not associated with recurrent pregnancy loss: an incident paired case-control study. Hum Reprod. 2007 Nov;22(11):2829-33. Abstract
21. Beever CL, Stephenson MD, Penaherrera MS, et al. Skewed X-chromosome inactivation is associated with trisomy in women ascertained on the basis of recurrent spontaneous abortion or chromosomally abnormal pregnancies. Am J Hum Genet. 2003 Feb;72(2):399-407.Full text Abstract
22. Chan YY, Jayaprakasan K, Zamora J, et al. The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review. Hum Reprod Update. 2011 Nov-Dec;17(6):761-71.Full text Abstract
23. Grimbizis GF, Camus M, Tarlatzis BC, et al. Clinical implications of uterine malformations and hysteroscopic treatment results. Hum Reprod Update. 2001 Mar-Apr;7(2):161-74.Full text Abstract
24. Valli E, Vaquero E, Lazzarin N, et al. Hysteroscopic metroplasty improves gestational outcome in women with recurrent spontaneous abortion. J Am Assoc Gynecol Laparosc. 2004 May;11(2):240-4. Abstract
25. National Institute for Health and Care Excellence. Hysteroscopic metroplasty of a uterine septum for recurrent miscarriage. January 2015 [internet publication].Full text
26. Drakeley AJ, Roberts D, Alfirevic Z. Cervical stitch (cerclage) for preventing pregnancy loss in women. Cochrane Database Syst Rev. 2003 Jan;2003(1):CD003253.Full text Abstract
27. Rai RS, Regan L, Clifford K, et al. Antiphospholipid antibodies and beta 2-glycoprotein-I in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Hum Reprod. 1995 Aug;10(8):2001-5. Abstract
28. Royal College of Obstetricians and Gynaecologists. Recurrent miscarriage: green-top guideline no. 17. Jun 2023 [internet publication].Full text Abstract
29. Knight JS, Branch DW, Ortel TL. Antiphospholipid syndrome: advances in diagnosis, pathogenesis, and management. BMJ. 2023 Feb 27;380:e069717.Full text Abstract
30. Arachchillage DJ, Platton S, Hickey K, et al. Guidelines on the investigation and management of antiphospholipid syndrome. Br J Haematol. 2024 Sep;205(3):855-80.Full text
31. Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost. 2006 Feb;4(2):295-306.Full text Abstract
32. Barbhaiya M, Zuily S, Naden R, et al. The 2023 ACR/EULAR antiphospholipid syndrome classification criteria. Arthritis Rheumatol. 2023 Oct;75(10):1687-702.Full text Abstract
33. Cavalcante MB, da Silva PHA, Carvalho TR, et al. Peripheral blood natural killer cell cytotoxicity in recurrent miscarriage: a systematic review and meta-analysis. J Reprod Immunol. 2023 Aug;158:103956. Abstract
34. Von Woon E, Greer O, Shah N, et al. Number and function of uterine natural killer cells in recurrent miscarriage and implantation failure: a systematic review and meta-analysis. Hum Reprod Update. 2022 Jun 30;28(4):548-82.Full text Abstract
35. Vomstein K, Feil K, Strobel L, et al. Immunological risk factors in recurrent pregnancy loss: guidelines versus current state of the art. J Clin Med. 2021 Feb 20;10(4):869.Full text Abstract
36. Meuleman T, Lashley LE, Dekkers OM, et al. HLA associations and HLA sharing in recurrent miscarriage: a systematic review and meta-analysis. Hum Immunol. 2015 May;76(5):362-73. Abstract
37. Wong LF, Porter TF, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev. 2014;(10):CD000112.Full text Abstract
38. Liu X, Chen Y, Ye C, et al. Hereditary thrombophilia and recurrent pregnancy loss: a systematic review and meta-analysis. Hum Reprod. 2021 Apr 20;36(5):1213-29.Full text Abstract
39. Robertson L, Wu O, Langhorne P, et al; Thrombosis: risk and economic assessment of thrombophilia screening (TREATS) study. Thrombophilia in pregnancy: a systematic review. Br J Haematol. 2006 Jan;132(2):171-96. Abstract
40. Shehata H, Ali A, Silva-Edge M, et al. Thrombophilia screening in women with recurrent first trimester miscarriage: is it time to stop testing? - a cohort study and systematic review of the literature. BMJ Open. 2022 Jul 13;12(7):e059519.Full text Abstract
41. Vomstein K, Herzog A, Voss P, et al. Recurrent miscarriage is not associated with a higher prevalence of inherited and acquired thrombophilia. Am J Reprod Immunol. 2021 Jan;85(1):e13327. Abstract
42. Arachchillage DJ, Mackillop L, Chandratheva A, et al. Thrombophilia testing: a British Society for Haematology guideline. Br J Haematol. 2022 Aug;198(3):443-58.Full text Abstract
43. American College of Obstetricians and Gynecologists. Practice bulletin no. 197: inherited thrombophilias in pregnancy. Obstet Gynecol. Jul 2018 [internet publication].Full text Abstract
44. Cocksedge KA, Li TC, Saravelos SH, et al. A reappraisal of the role of polycystic ovary syndrome in recurrent miscarriage. Reprod Biomed Online. 2008 Jul;17(1):151-60. Abstract
45. The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004 Jan;19(1):41-7.Full text Abstract
46. Craig LB, Ke RW, Kutteh WH. Increased prevalence of insulin resistance in women with a history of recurrent pregnancy loss. Fertil Steril. 2002 Sep;78(3):487-90. Abstract
47. Rai R, Backos M, Rushworth F, et al. Polycystic ovaries and recurrent miscarriage: a reappraisal. Hum Reprod. 2000 Mar;15(3):612-5.Full text Abstract
48. Arredondo F, Noble LS. Endocrinology of recurrent pregnancy loss. Semin Reprod Med.2006 Feb;24(1):33-9. Abstract
49. Haas DM, Hathaway TJ, Ramsey PS. Progestogen for preventing miscarriage in women with recurrent miscarriage of unclear etiology. Cochrane Database Syst Rev. 2019 Nov 20;2019(11):CD003511.Full text Abstract
50. Devall AJ, Papadopoulou A, Podesek M, et al. Progestogens for preventing miscarriage: a network meta-analysis. Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD013792.Full text Abstract
51. Coomarasamy A, Williams H, Truchanowicz E, et al. A randomized trial of progesterone in women with recurrent miscarriages. N Engl J Med. 2015 Nov 26;373(22):2141-8. Abstract
52. Coomarasamy A, Devall AJ, Brosens JJ, et al. Micronized vaginal progesterone to prevent miscarriage: a critical evaluation of randomized evidence. Am J Obstet Gynecol. 2020 Aug;223(2):167-76.Full text Abstract
53. Dlugi AM. Hyperprolactinemic recurrent spontaneous pregnancy loss: a true clinical entity or a spurious finding? Fertil Steril. 1998 Aug;70(2):253-5. Abstract
54. Abalovich M, Gutierrez S, Alcaraz G, et al. Overt and subclinical hypothyroidism complicating pregnancy. Thyroid. 2002 Jan;12(1):63-8. Abstract
55. Prummel MF, Wiersinga WM. Thyroid autoimmunity and miscarriage. Eur J Endocrinol. 2004 Jun;150(6):751-5. Abstract
56. Mills JL, Simpson JL, Driscoll SG, et al. Incidence of spontaneous abortion among normal women and insulin-dependent diabetic women whose pregnancies were identified within 21 days of conception. N Engl J Med. 1988 Dec 22;319(25):1617-23. Abstract
57. Summers PR. Microbiology relevant to recurrent miscarriage. Clin Obstet Gynecol. 1994 Sep;37(3):722-9. Abstract
58. Hay PE, Lamont RF, Taylor-Robinson D, et al. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ. 1994 Jan 29;308(6924):295-8.Full text Abstract
59. Matovina M, Husnjak K, Milutin N, et al. Possible role of bacterial and viral infections in miscarriages. Fertil Steril. 2004 Mar;81(3):662-9. Abstract
60. Pirtea P, Cicinelli E, De Nola R, et al. Endometrial causes of recurrent pregnancy losses: endometriosis, adenomyosis, and chronic endometritis. Fertil Steril. 2021 Mar;115(3):546-60.Full text Abstract
61. Santoro A, Travaglino A, Inzani F, et al. The role of plasma cells as a marker of chronic endometritis: a systematic review and meta-analysis. Biomedicines. 2023 Jun 15;11(6):1714.Full text Abstract
62. Greenwood SM, Moran JJ. Chronic endometritis: morphologic and clinical observations. Obstet Gynecol. 1981 Aug;58(2):176-84. Abstract
63. Bayer-Garner IB, Korourian S. Plasma cells in chronic endometritis are easily identified when stained with syndecan-1. Mod Pathol. 2001 Sep;14(9):877-9. Abstract
64. McQueen DB, Perfetto CO, Hazard FK, et al. Pregnancy outcomes in women with chronic endometritis and recurrent pregnancy loss. Fertil Steril. 2015 Oct;104(4):927-31.Full text Abstract
65. Cicinelli E, Vitagliano A, Kumar A, et al. Unified diagnostic criteria for chronic endometritis at fluid hysteroscopy: proposal and reliability evaluation through an international randomized-controlled observer study. Fertil Steril. 2019 Jul;112(1):162-73.e2.Full text Abstract
66. McQueen DB, Zhang J, Robins JC. Sperm DNA fragmentation and recurrent pregnancy loss: a systematic review and meta-analysis. Fertil Steril. 2019 Jul;112(1):54-60.e3. Abstract
67. Yifu P, Lei Y, Shaoming L, et al. Sperm DNA fragmentation index with unexplained recurrent spontaneous abortion: A systematic review and meta-analysis. J Gynecol Obstet Hum Reprod. 2020 Apr 26;:101740. Abstract
68. Papas RS, Kutteh WH. A new algorithm for the evaluation of recurrent pregnancy loss redefining unexplained miscarriage: review of current guidelines. Curr Opin Obstet Gynecol. 2020 Oct;32(5):371-79.Full text Abstract
69. Gardella JR, Hill JA 3rd. Environmental toxins associated with recurrent pregnancy loss. Semin Reprod Med. 2000;18(4):407-24. Abstract
70. Kline J, Shrout P, Stein Z, et al. Drinking during pregnancy and spontaneous abortion. Lancet. 1980 Jul 26;2(8187):176-80. Abstract
71. Signorello LB, McLaughlin JK. Maternal caffeine consumption and spontaneous abortion: a review of the epidemiologic evidence. Epidemiology. 2004 Mar;15(2):229-39. Abstract
72. Sata F, Yamada H, Suzuki K, et al. Caffeine intake, CYP1A2 polymorphism and the risk of recurrent pregnancy loss. Mol Hum Reprod. 2005 May;11(5):357-60.Full text Abstract
73. Brent RL. The effects of embryonic and fetal exposure to x-ray, microwaves, and ultrasound. Clin Perinatol. 1986 Sep;13(3):615-48. Abstract
74. National Institute for Health and Care Excellence. Ectopic pregnancy and miscarriage: diagnosis and initial management. Aug 2023 [internet publication].Full text
75. Barnhart KT, Sammel MD, Rinaudo PF, et al. Symptomatic patients with an early viable intrauterine pregnancy: HCG curves redefined. Obstet Gynecol. 2004 Jul;104(1):50-5. Abstract
76. Royal College of Obstetricians and Gynaecologists. Diagnosis and management of ectopic pregnancy. Green-top guideline no. 21. November 2016 [internet publication].Full text
77. Kim C, Barnard S, Neilson JP, et al. Medical treatments for incomplete miscarriage. Cochrane Database Syst Rev. 2017 Jan 31;1:CD007223.Full text Abstract
78. Neill S, Hoe E, Fortin J, et al. Management of early pregnancy loss among obstetrician-gynecologists in Massachusetts and barriers to mifepristone use. Contraception. 2023 Oct;126:110108. Abstract
79. Ghosh J, Papadopoulou A, Devall AJ, et al. Methods for managing miscarriage: a network meta-analysis. Cochrane Database Syst Rev. 2021 Jun 1;6(6):CD012602.Full text Abstract
80. National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention. What is stillbirth?. Sep 2022 [internet publication].Full text
81. Jauniaux E, Farquharson RG, Christiansen OB, et al. Evidence-based guidelines for the investigation and medical treatment of recurrent miscarriage. Hum Reprod. 2006 Sep;21(9):2216-22.Full text Abstract
82. Bradley LA, Palomaki GE, Bienstock J, et al. Can Factor V Leiden and prothrombin G20210A testing in women with recurrent pregnancy loss result in improved pregnancy outcomes?: Results from a targeted evidence-based review. Genet Med. 2012 Jan;14(1):39-50. Abstract
83. Royal College of Obstetricians and Gynaecologists. The role of natural killer cells in human fertility. Scientific impact paper no. 53. December 2016 [internet publication].Full text
84. Foyouzi N, Cedars MI, Huddleston HG. Cost-effectiveness of cytogenetic evaluation of products of conception in the patient with a second pregnancy loss. Fertil Steril. 2012 Jul;98(1):151-5. Abstract
85. Bernardi LA, Plunkett BA, Stephenson MD. Is chromosome testing of the second miscarriage cost saving? A decision analysis of selective versus universal recurrent pregnancy loss evaluation. Fertil Steril. 2012 Jul;98(1):156-61. Abstract
86. Dhillon RK, Hillman SC, Morris RK, et al. Additional information from chromosomal microarray analysis (CMA) over conventional karyotyping when diagnosing chromosomal abnormalities in miscarriage: a systematic review and meta-analysis. BJOG. 2014 Jan;121(1):11-21.Full text Abstract
87. Ikuma S, Sato T, Sugiura-Ogasawara M, et al. Preimplantation genetic diagnosis and natural conception: a comparison of live birth rates in patients with recurrent pregnancy loss associated with translocation. PLoS One. 2015;10(6):e0129958.Full text Abstract
88. Audibert F, Wilson RD, Allen V, et al. Preimplantation genetic testing. J Obstet Gynaecol Can. 2009 Aug;31(8):761-75. Abstract
89. ESHRE Capri Workshop Group. Genetic aspects of female reproduction. Hum Reprod Update. 2008 Jul-Aug;14(4):293-307.Full text Abstract
90. Subtil D, Brabant G, Tilloy E, et al. Early clindamycin for bacterial vaginosis in pregnancy (PREMEVA): a multicentre, double-blind, randomised controlled trial. Lancet. 2018 Nov 17;392(10160):2171-79. Abstract
91. Brocklehurst P, Gordon A, Heatley E, et al. Antibiotics for treating bacterial vaginosis in pregnancy. Cochrane Database Syst Rev. 2013 Jan 31;(1):CD000262.Full text Abstract
92. Cicinelli E, Matteo M, Tinelli R, et al. Chronic endometritis due to common bacteria is prevalent in women with recurrent miscarriage as confirmed by improved pregnancy outcome after antibiotic treatment. Reprod Sci. 2014 May;21(5):640-7. Abstract
93. Queensland Health. Queensland clinical guidelines: early pregnancy loss. 2025 [internet publication].Full text
94. Saravelos SH, Cocksedge KA, Li TC. Prevalence and diagnosis of congenital uterine anomalies in women with reproductive failure: a critical appraisal. Hum Reprod Update. 2008 Sep-Oct;14(5):415-29. Abstract
95. ESHRE Guideline Group on RPL, Bender Atik R, Christiansen OB, et al. ESHRE guideline: recurrent pregnancy loss. Hum Reprod Open. 2018;2018(2):hoy004.Full text Abstract
96. Grimbizis GF, Di Spiezio Sardo A, Saravelos SH, et al. The Thessaloniki ESHRE/ESGE consensus on diagnosis of female genital anomalies. Hum Reprod. 2016 Jan;31(1):2-7.Full text Abstract
97. Crane JM, Hutchens D. Transvaginal sonographic measurement of cervical length to predict preterm birth in asymptomatic women at increased risk: a systematic review. Ultrasound Obstet Gynecol. 2008 May;31(5):579-87. Abstract
Use of this content is subject to our disclaimer